Purchase Order 75N93020P01407
Award Date 9/25/20
Potential Completion Date 12/1/20
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $249,996 firm fixed price purchase order to Gene By Gene, LTD for clinical grade whole genome sequencing services. The contract calls for Gene By Gene to deliver these sequencing services from its Houston, Texas facility between September 1, 2023 and December 31, 2023 to support NIAID's research efforts in the areas of allergy and infectious disease. No...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $6,829.94 contract does not have a set-aside designation. Illumina has previously received federal prime contracts and subcontracts from agencies like the Centers for Disease Control and Prevention (CDC), Department of...
- This federal contract award to Genewiz, LLC, a global contract research organization, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $5,300.00 firm fixed price purchase order is for other functions - whole genome sequencing of 8 samples. The award has no set-aside designation. Through this contract, Genewiz will provide specialized genomic services, including next-generation sequencing, to support research...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $33,646.00 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for a 1-year license to access the Human Gene Mutation Database, which provides data on approximately 200,000 human genomic mutations. This data supports NIAID's efforts to build a custom bioinformatics...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $3,409.10 contract is for the provision of sequencing systems, reagents, consumables, and related support services to support genomic research and diagnostics. Illumina has a history of prior prime federal contract and...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $50,000 contract is for the provision of sequencing systems, consumables, and support services to assist with genomic research and diagnostics. Illumina has a history of providing these types of products and services to...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Diagenode, LLC, a for-profit limited liability company, to provide epigenomic sequencing services and bioinformatics analysis. The one-year contract, valued at $61,310.00, does not have a set-aside designation. The services will support the National Institute of Allergy and Infectious Diseases' research on variable penetrance...
- This federal contract award, identified as HHSN272201300421P, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the Vaccine and Gene Therapy Institute of Florida Corp. The $7,440.00 firm fixed-price purchase order is for an ILLUMINA WG BEADCHIP COMPLETE 1-CYCLE ASSAY. The contract has a completion date of May 17, 2013 and was awarded on April 17, 2013. The award was not set aside for any specific business...